Case report: Cryoablation as a novel bridging strategy prior to CAR-T cell therapy for B cell malignancies with bulky disease

Case report: Cryoablation as a novel bridging strategy prior to CAR-T cell therapy for B cell malignancies with bulky disease

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a powerful immunotherapy in relapsed/refractory (R/R) hematological malignancies, especially in R/R B-cell acute lymphocytic leukemia (B-ALL), non-Hodgkin lymphoma (NHL), and multiple myeloma (MM). To prevent disease progression and reduc...

Full description

Bibliographic Details
Main Authors: Xiaomin Zhang, Jinming Wu, Liangliang Qiao, Lixuan Chen, Chaolin Chen, Hui Zhang, Rongcheng Luo, Yang Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
CAR-T cell therapy
cryoablation
multiple myeloma
primary cutaneous diffuse large B-cell lymphoma leg type
bridging therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1008828/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1008828/full

Similar Items